Yu‐Ning Lin
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents 4
- Cell Biology top 10%
- Urology top 10%
- Urinary Bladder and Prostate Research 3
- Urological Disorders and Treatments 3
-
- Pelvic floor disorders treatments 4
-
- Metabolomics and Mass Spectrometry Studies 3
- Genomics, phytochemicals, and oxidative stress 2
-
- Cancer Mechanisms and Therapy 3
-
- Neuroinflammation and Neurodegeneration Mechanisms 2
Yu‐Ning Lin
29 papers receiving 742 citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Toxicology 47
- Biological Psychiatry 22
- Cell Biology 123
- Urology 38
- Epidemiology 178
Countries citing papers authored by Yu‐Ning Lin
This map shows the geographic impact of Yu‐Ning Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ning Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ning Lin more than expected).
Fields of papers citing papers by Yu‐Ning Lin
This network shows the impact of papers produced by Yu‐Ning Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ning Lin. The network helps show where Yu‐Ning Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yu‐Ning Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 9 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 7 | |
| 10 | 2021 | 6 | |
| 11 | 2021 | 7 | |
| 12 | 2020 | 15 | |
| 13 | 2020 | 0 | |
| 14 | 2020 | 5 | |
| 15 | 2019 | 16 | |
| 16 | 2019 | 27 | |
| 17 | 2019 | 18 | |
| 18 | 2018 | 7 | |
| 19 | 2017 | 26 | |
| 20 | 2013 | 18 |
About Yu‐Ning Lin
Yu‐Ning Lin is a scholar working on Toxicology, Biological Psychiatry and Urology, having authored 32 papers that have together received 750 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (4 papers), Pelvic floor disorders treatments (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Urinary Bladder and Prostate Research (3 papers), Cancer Mechanisms and Therapy (3 papers), Urological Disorders and Treatments (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). The work is most often cited by research in Toxicology (47 citations), Biological Psychiatry (22 citations) and Cell Biology (123 citations). Yu‐Ning Lin has collaborated with scholars based in Taiwan, China and Hong Kong. Frequent co-authors include Yanfei Wei, Wanjun Chen, Mei Jiang, Tiejian Zhao, Chao‐Jung Chen, T. M. Lin, Jiaxin Yu, Wen‐Chi Chen, Huey‐Yi Chen and Yung‐Hsiang Chen. Their work appears in journals such as Frontiers in Pharmacology, European Journal of Obstetrics & Gynecology and Reproductive Biology, Phytomedicine, Biomedicine & Pharmacotherapy and Journal of Personalized Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.